Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Petrella, Laurica A.
Sambol, Susan P.
Cheknis, Adam
Nagaro, Kristin
Kean, Yin
Sears, Pamela S.
Babakhani, Farah
Johnson, Stuart
and
Gerding, Dale N.
2012.
Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain.
Clinical Infectious Diseases,
Vol. 55,
Issue. 3,
p.
351.
Hall, Aron J.
Curns, Aaron T.
McDonald, L. Clifford
Parashar, Umesh D.
and
Lopman, Ben A.
2012.
The Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999–2007.
Clinical Infectious Diseases,
Vol. 55,
Issue. 2,
p.
216.
Wang, Michael S.
Evans, Charlesnika T.
Rodriguez, Tulio
Gerding, Dale N.
and
Johnson, Stuart
2013.
Clostridium difficileInfection and Limitations of Markers for Severity in Patients with Hematologic Malignancy.
Infection Control & Hospital Epidemiology,
Vol. 34,
Issue. 2,
p.
127.
Hebert, Courtney
Du, Hongyan
Peterson, Lance R.
and
Robicsek, Ari
2013.
Electronic Health Record–Based Detection of Risk Factors for Clostridium difficile Infection Relapse.
Infection Control & Hospital Epidemiology,
Vol. 34,
Issue. 4,
p.
407.
Sears, Pamela
Ichikawa, Yoshi
Ruiz, Nancy
and
Gorbach, Sherwood
2013.
Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.
Annals of the New York Academy of Sciences,
Vol. 1291,
Issue. 1,
p.
33.
Halabi, Wissam J.
Nguyen, Vinh Q.
Carmichael, Joseph C.
Pigazzi, Alessio
Stamos, Michael J.
and
Mills, Steven
2013.
Clostridium Difficile Colitis in the United States: A Decade of Trends, Outcomes, Risk Factors for Colectomy, and Mortality after Colectomy.
Journal of the American College of Surgeons,
Vol. 217,
Issue. 5,
p.
802.
DePestel, Daryl D.
and
Aronoff, David M.
2013.
Epidemiology of Clostridium difficile Infection.
Journal of Pharmacy Practice,
Vol. 26,
Issue. 5,
p.
464.
Pacheco, Susan M.
and
Johnson, Stuart
2013.
Important clinical advances in the understanding of Clostridium difficile infection.
Current Opinion in Gastroenterology,
Vol. 29,
Issue. 1,
p.
42.
Eyre, David W
and
Walker, A Sarah
2013.
Clostridium difficilesurveillance: harnessing new technologies to control transmission.
Expert Review of Anti-infective Therapy,
Vol. 11,
Issue. 11,
p.
1193.
Johnson, S.
2014.
Editorial Commentary: Changing Epidemiology of Clostridium difficile and Emergence of New Virulent Strains.
Clinical Infectious Diseases,
Vol. 58,
Issue. 12,
p.
1731.
Dubberke, Erik R.
Carling, Philip
Carrico, Ruth
Donskey, Curtis J.
Loo, Vivian G.
McDonald, L. Clifford
Maragakis, Lisa L.
Sandora, Thomas J.
Weber, David J.
Yokoe, Deborah S.
and
Gerding, Dale N.
2014.
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update.
Infection Control & Hospital Epidemiology,
Vol. 35,
Issue. 6,
p.
628.
Dubberke, Erik R.
Carling, Philip
Carrico, Ruth
Donskey, Curtis J.
Loo, Vivian G.
McDonald, L. Clifford
Maragakis, Lisa L.
Sandora, Thomas J.
Weber, David J.
Yokoe, Deborah S.
and
Gerding, Dale N.
2014.
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update.
Infection Control & Hospital Epidemiology,
Vol. 35,
Issue. 6,
p.
628.
Dubberke, Erik R.
Carling, Philip
Carrico, Ruth
Donskey, Curtis J.
Loo, Vivian G.
McDonald, L. Clifford
Maragakis, Lisa L.
Sandora, Thomas J.
Weber, David J.
Yokoe, Deborah S.
and
Gerding, Dale N.
2014.
Strategies to PreventClostridium difficileInfections in Acute Care Hospitals: 2014 Update.
Infection Control & Hospital Epidemiology,
Vol. 35,
Issue. S2,
p.
S48.
Xie, Jinfu
Horton, Melanie
Zorman, Julie
Antonello, Joseph M.
Zhang, Yuhua
Arnold, Beth A.
Secore, Susan
Xoconostle, Rachel
Miezeiewski, Matthew
Wang, Su
Price, Colleen E.
Thiriot, David
Goerke, Aaron
Gentile, Marie-Pierre
Skinner, Julie M.
Heinrichs, Jon H.
and
Hodinka, R. L.
2014.
Development and Optimization of a High-Throughput Assay To Measure Neutralizing Antibodies against Clostridium difficile Binary Toxin.
Clinical and Vaccine Immunology,
Vol. 21,
Issue. 5,
p.
689.
Gerding, Dale N
Johnson, Stuart
Rupnik, Maja
and
Aktories, Klaus
2014.
Clostridium difficilebinary toxin CDT.
Gut Microbes,
Vol. 5,
Issue. 1,
p.
15.
Johnson, Stuart
Louie, Thomas J.
Gerding, Dale N.
Cornely, Oliver A.
Chasan-Taber, Scott
Fitts, David
Gelone, Steven P.
Broom, Colin
and
Davidson, David M.
2014.
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials.
Clinical Infectious Diseases,
Vol. 59,
Issue. 3,
p.
345.
Jump, Robin L. P.
and
Donskey, Curtis J.
2015.
Clostridium difficile in the Long-Term Care Facility: Prevention and Management.
Current Geriatrics Reports,
Vol. 4,
Issue. 1,
p.
60.
Scardina, T.
Labuszewski, L.
Pacheco, S.M.
Adams, W.
Schreckenberger, P.
and
Johnson, S.
2015.
Clostridium difficileInfection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic Setting.
Infection Control & Hospital Epidemiology,
Vol. 36,
Issue. 3,
p.
280.
Kociolek, Larry K.
Patel, Sameer J.
Shulman, Stanford T.
and
Gerding, Dale N.
2015.
Molecular Epidemiology ofClostridium difficileInfections in Children: A Retrospective Cohort Study.
Infection Control & Hospital Epidemiology,
Vol. 36,
Issue. 4,
p.
445.
Marsh, Jane W.
and
Harrison, Lee H.
2015.
Antimicrobial Resistance and Food Safety.
p.
181.